iRadimed (IRMD) vs Kestra Medical Technologies (KMTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iRadimed (IRMD) has outperformed Kestra Medical Technologies (KMTS) over the past year, gaining 11.7% versus a gain of 7.4%. Kestra Medical Technologies is the larger company by market cap ($1.53 billion vs $1.10 billion), about 1.4 times the size. iRadimed pays a dividend yielding 0.90%, while Kestra Medical Technologies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRMD | KMTS |
|---|---|---|
| Share price | $85.88 | $25.77 |
| Market cap | $1.10B | $1.53B |
| 1-day change | +0.48% | -2.72% |
| YTD return | -11.72% | -2.83% |
| 1-year return | +11.72% | +7.37% |
| 5-year return | +134.20% | — |
| P/E ratio (TTM) | 47.98 | — |
| Forward P/E | 35.01 | — |
| EPS (TTM) | $1.79 | $-2.67 |
| Dividend yield | 0.90% | 0.00% |
| Annual dividend | $0.77 | $0.00 |
| Revenue (latest FY) | — | $95.13M |
| Revenue growth (YoY) | — | +59.03% |
| Net income (latest FY) | — | $-131.61M |
| Gross margin | — | 51.37% |
| Operating margin | — | -141.64% |
| Net margin | — | -138.36% |
| 52-week high | $107.90 | $30.00 |
| 52-week low | $71.34 | $17.34 |
| Distance from 52-week high | -20.41% | -14.10% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +37.40% | +17.54% |
| Average volume | 125.83K | 357.86K |
| Shares outstanding | 12.79M | 59.56M |
| Employees | 166 | 443 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
About Kestra Medical Technologies
KMTS stock →Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
Health Care · Medical/Dental Instruments · 443 employees
IRMD vs KMTS FAQ
Which is bigger, iRadimed or Kestra Medical Technologies?
Kestra Medical Technologies (KMTS) is larger, with a market capitalization of $1.53B compared with $1.10B for iRadimed (IRMD).
Which stock has performed better over the past year, IRMD or KMTS?
IRMD returned +11.72% over the past 12 months, compared with +7.37% for KMTS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, iRadimed or Kestra Medical Technologies?
iRadimed pays a dividend yielding 0.90%, while Kestra Medical Technologies does not currently pay a regular dividend.
Are iRadimed and Kestra Medical Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.